B. Schwerer

533 total citations
24 papers, 431 citations indexed

About

B. Schwerer is a scholar working on Neurology, Cellular and Molecular Neuroscience and Infectious Diseases. According to data from OpenAlex, B. Schwerer has authored 24 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Infectious Diseases. Recurrent topics in B. Schwerer's work include Peripheral Neuropathies and Disorders (9 papers), Hereditary Neurological Disorders (9 papers) and Leprosy Research and Treatment (6 papers). B. Schwerer is often cited by papers focused on Peripheral Neuropathies and Disorders (9 papers), Hereditary Neurological Disorders (9 papers) and Leprosy Research and Treatment (6 papers). B. Schwerer collaborates with scholars based in Austria, United States and Ireland. B. Schwerer's co-authors include H. Bernheimer, Hans Lassmann, K. Kitz, Anthony P. Moran, William R. Levis, Michael Bach, T Berger, Harry C. Meeker, Eugene A. Sersen and Georgia Schuller‐Levis and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Neurochemistry and Infection and Immunity.

In The Last Decade

B. Schwerer

24 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Schwerer Austria 13 163 128 121 103 78 24 431
Wouter van Rijs Netherlands 18 354 2.2× 231 1.8× 92 0.8× 238 2.3× 110 1.4× 25 701
Eric R. Wagner United States 10 275 1.7× 223 1.7× 42 0.3× 165 1.6× 136 1.7× 16 571
Paola Amicucci Italy 11 45 0.3× 83 0.6× 172 1.4× 32 0.3× 218 2.8× 20 550
Carl Granert Sweden 11 45 0.3× 27 0.2× 38 0.3× 464 4.5× 75 1.0× 14 692
Nobuo Hirota Japan 11 50 0.3× 12 0.1× 51 0.4× 42 0.4× 96 1.2× 32 419
Sérgio Luiz Gomes Antunes Brazil 14 105 0.6× 28 0.2× 424 3.5× 54 0.5× 51 0.7× 34 554
Bronwen R. Burton United Kingdom 11 28 0.2× 37 0.3× 41 0.3× 353 3.4× 143 1.8× 13 650
Nathalie H. Gendron Canada 13 34 0.2× 31 0.2× 66 0.5× 80 0.8× 371 4.8× 14 554
Jenny Ahlqvist Sweden 11 24 0.1× 26 0.2× 94 0.8× 70 0.7× 49 0.6× 13 459
Vinuth N. Puttamallesh India 12 45 0.3× 16 0.1× 53 0.4× 55 0.5× 233 3.0× 17 394

Countries citing papers authored by B. Schwerer

Since Specialization
Citations

This map shows the geographic impact of B. Schwerer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Schwerer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Schwerer more than expected).

Fields of papers citing papers by B. Schwerer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Schwerer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Schwerer. The network helps show where B. Schwerer may publish in the future.

Co-authorship network of co-authors of B. Schwerer

This figure shows the co-authorship network connecting the top 25 collaborators of B. Schwerer. A scholar is included among the top collaborators of B. Schwerer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Schwerer. B. Schwerer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Finsterer, Josef, et al.. (1999). Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy.. PubMed. 18(1). 31–6. 8 indexed citations
4.
Gatterbauer, Brigitte, et al.. (1998). Antiglycosphingolipid Immune Responses in Neurology: The Vienna Experience with Isotypes, Subclasses, and Diseasea. Annals of the New York Academy of Sciences. 845(1). 353–362. 6 indexed citations
5.
Bernheimer, H., et al.. (1997). Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome. Infection and Immunity. 65(10). 4038–4042. 40 indexed citations
6.
Saad, Maria Helena Féres, B J Gormus, Sung‐Rae Cho, H. Bernheimer, & B. Schwerer. (1995). Detection of IgA anti-PGL-I specific antigen toMycobacterium lepraein mangabey monkeys inoculated withM. leprae. Leprosy Review. 66(4). 296–306. 1 indexed citations
7.
Schwerer, B., et al.. (1995). Antibody cross-reactivities between gangliosides and lipopolysaccharides of Campylobacter jejuni serotypes associated with Guillain-Barré syndrome. Journal of Endotoxin Research. 2(6). 395–403. 33 indexed citations
8.
Seiser, Andreas, et al.. (1994). GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome.. PubMed. 106(6). 159–63. 4 indexed citations
9.
Kühn, Benjamin, et al.. (1992). Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen. Clinical & Experimental Immunology. 87(3). 398–403. 32 indexed citations
10.
Schwerer, B., H. Bernheimer, J Rádl, et al.. (1989). IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: Subclass distribution and relation to disease activity. Clinical Immunology and Immunopathology. 53(2). 202–211. 6 indexed citations
11.
Schwerer, B., Michael Bach, & H. Bernheimer. (1987). ELISA for determination of albumin in the nanogram range: Assay in cerebrospinal fluid and comparison with radial immunodiffusion. Clinica Chimica Acta. 163(3). 237–244. 37 indexed citations
12.
Schwerer, B., Hans Lassmann, K. Kitz, & H. Bernheimer. (1986). Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathologica. 72(1). 55–61. 40 indexed citations
13.
Schwerer, B., et al.. (1985). IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.. PubMed. 2(2-4). 394–402. 16 indexed citations
14.
Lassmann, Hans, Gerda Suchanek, K. Kitz, et al.. (1984). Antibodies in the pathogenesis of demyelination in chronic relapsing EAE (cr-EAE).. PubMed. 146. 165–70. 12 indexed citations
15.
Schwerer, B., K. Kitz, Hans Lassmann, & H. Bernheimer. (1984). Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis. Journal of Neuroimmunology. 7(2-3). 107–119. 28 indexed citations
16.
Schwerer, B., et al.. (1984). Cellular and humoral immune response to MBP during the course of chronic relapsing EAE.. PubMed. 146. 187–92. 7 indexed citations
18.
Schwerer, B., Hans Lassmann, & H. Bernheimer. (1982). ANTISERA AGAINST GANGLIOSIDE GM2: IMMUNOCHEMICAL AND IMMUNOHISTOLOGICAL STUDIES. Neuropathology and Applied Neurobiology. 8(3). 217–226. 5 indexed citations
19.
Schwerer, B., Hans Lassmann, K. Kitz, H. Bernheimer, & Henryk M. Wı́sniewski. (1981). Fractionation of Spinal Cord Tissue Affects its Activity to Induce Chronic Relapsing Experimental Encephalomyelitis. PubMed. 7. 165–168. 4 indexed citations
20.
Schwerer, B. & H. Bernheimer. (1978). LEUKOCYTE PPD‐PEROXIDASE ACTIVITY WITH POLYUNSATURATED FATTY ACID HYDROPEROXIDES: NORMAL VALUES IN BATTEN'S DISEASE. Journal of Neurochemistry. 31(2). 457–460. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026